XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenue $ 30,651 $ 35,129
Operating costs and expenses    
Cost of revenue [1] 9,323 10,161
Sales and marketing 6,017 7,184
Product and technology 9,616 9,578
General and administrative [1] 7,159 10,006
Depreciation and amortization 1,839 4,201
Total operating costs and expenses 33,954 41,130
Operating loss (3,303) (6,001)
Interest expenses, net 1,132 1,716
Other income, net (26) (9,292)
(Loss) income before income taxes (4,409) 1,575
Income tax (benefit) expense (249) 74
Net (loss) income $ (4,160) $ 1,501
(Loss) earnings per share, basic $ (0.09) $ 0.03
(Loss) earnings per share, diluted $ (0.09) $ 0.03
Weighted average ordinary shares outstanding, basic 45,134,267 42,982,255
Weighted average ordinary shares outstanding, diluted [2] 45,134,267 47,200,182
[1] Excludes depreciation and amortization expense.
[2] For the three months ended March 31, 2024, potentially dilutive securities consisting of certain share options, nonvested restricted shares and restricted share units totaling 4,197,808 shares were excluded from the computation of diluted weighted average ordinary shares outstanding as inclusion would be anti-dilutive due to the Company incurring a net loss during the three months ended March 31, 2024. For the three months ended, March 31, 2023, 2,448,873 share options with an exercise price greater than the market price of the Company’s ordinary shares were excluded from the computation of diluted weighted average ordinary shares outstanding.